| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.14B | +2.0% |
| Cost of Revenue | $430.9M | -11.4% |
| Gross Profit | $709.1M | +12.4% |
| R&D Expense | $221.5M | +4.5% |
| SG&A Expense | $139.6M | +39.7% |
| Operating Income | $16.9M | +126.0% |
| Interest Expense | $15.9M | -6.2% |
| Pre-tax Income | $4.3M | +105.5% |
| Income Tax | $11.7M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $231.7M | +47.9% |
| Accounts Receivable | $126.7M | +41.5% |
| Inventory | $102.6M | -27.3% |
| Current Assets | $535.3M | +14.6% |
| Total Assets | $1.15B | +10.6% |
| Current Liabilities | $587.9M | +13.6% |
| Long-term Debt | $180.0M | -5.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $152.0M | +174.0% |
| Capital Expenditures | $24.7M | +36.4% |
| Investing Cash Flow | -$24.7M | -36.4% |
| Financing Cash Flow | -$52.6M | +54.3% |
| Free Cash Flow | $127.3M | +240.7% |
| +38.7% |
| Net Income | -$7.5M | +91.3% |
| EPS (Basic) | -$0.06 | +90.9% |
| EPS (Diluted) | -$0.06 | +90.9% |
| Stockholders' Equity |
| $65.6M |
| +159.4% |